Vaultly tag

Radiopharmaceutical sector news and market signals

Public Vaultly articles where Radiopharmaceutical sector appears among the affected assets. Premium market intelligence becomes searchable here after 24 hours.

Cyclopharm H1 Revenue Surge Signals Growth in Radiopharmaceutical ETFs

ETFs & MarketsBasic

Medium 7/10CYC.AX Healthcare ETFs

Cyclopharm H1 Revenue Surge Signals Growth in Radiopharmaceutical ETFs

Cyclopharm has reported record revenue for the first half of 2026, driven by the accelerating rollout of its Technegas technology in the United States. This performance indicates a potential shift in capital allocation toward specialized diagnostic imaging providers within the broader healthcare market.

September 2, 2026Published 2 hours ago